Find expert answers to your health questions so you can make the best decisions for yourself and your family.Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.Find expert answers to your health questions so you can make the best decisions for yourself and your family.Health conditions
Medications & treatment
Access & affordability
Medication discounts
Board-certified physician specializing in radioligand therapy for metastatic prostate and neuroendocrine cancers
Residency training in radiation oncology at Yale-New Haven Hospital/Yale School of Medicine
Specialty training at the Nuclear Medicine and Radiomolecular Theranostics Clinic, ENETS Center of Excellence, Zentralklinik, Bad Berka, Germany
Passionate about providing the most optimal, personalized, and state-of-the-art care possible to patients living with cancer
Brandon R. Mancini, MD, MBA, FACRO, serves as medical director at BAMF Health in Grand Rapids, MI, in the emerging field of theranostics. His clinical focus is treating people with metastatic prostate and neuroendocrine cancers.
Dr. Mancini has also worked as clinical assistant professor at Western Michigan University School of Medicine and sits on multiple committees of the American College of Radiation Oncology (ACRO). From 2016 to 2022, he practiced radiation oncology as well. He has contributed to and published several abstracts, book chapters, and manuscripts in prestigious national and international journals.
Brandon R. Mancini, MD, MBA, FACRO, received his bachelor’s degree from the University of Michigan. Afterward, he went on to earn his medical degree from Wayne State University School of Medicine.
Dr. Mancini then completed an internal medicine internship and residency in therapeutic radiology (radiation oncology) at Yale New Haven Hospital/Yale School of Medicine in New Haven, Connecticut. During the final year of his residency, he served as chief resident.
He also received his Master of Business Administration from Yale School of Management and his Fellow of the American College of Radiation Oncology (FACRO) from the American College of Radiation Oncology.
